Registro:

Referencias:

• Akerbonn, T.P., Sies, H., Assay of glutathione, glutathione disulfides and glutathione mixed disulfides in biological samples (1981) Meth Enzymol, 77, pp. 373-382
• Albers, D.S., Bea, M.F., Standaert, D.G., Oxidative markers of injury in MPP+ and malonate-treated rat mesencephalic cultures (1998) Soc Neurosci Abstr, 24 (2), p. 2157
• (1994) Diagnostic and statistical manual of mental disorders (DSM IV), 4th edn, , American Psychiatric Association, Washington
• Anglade, P., Vyas, S., Hirsch, E.C., Agid, Y., Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging (1997) Histol Histopathol, 12 (3), pp. 603-610
• Aoki, M., Ogasawa, M., Matsubara, Y., Narisawa, K., Nakamura, S., Itoyama, Y., Abe, K., Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: A possible new subtype of familial ALS (1994) J Neurol Sci, 126, pp. 77-83
• Ben-Shachar, D., Riederer, P., Youdim, M.B., Iron-melanin interaction and lipid peroxidation: Implications for Parkinson's disease (1991) J Neurochem, 57, pp. 1609-1614
• Blessed, G., Tomlinson, B.E., Roth, M., The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects (1968) Br J Psychiatry, 114, pp. 797-811
• Chance, B., Sies, H., Boveris, A., Hydroperoxide metabolism in mammalian organs (1979) Physiol Rev, 59, pp. 527-605
• Chui, H.C., Victoroff, J.I., Margolin, D., Jagust, W., Shankle, R., Katzman, R., Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers (1992) Neurology, 42, pp. 473-480
• Cleeter, M.W., Cooper, J.M., Schapira, A.H., Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenyl-pyridinium: Evidence for free radical involvement (1992) J Neurochem, 58, pp. 786-789
• De Renzi, E., Faglioni, P., Normative data and screening power of a shortened version of the Token Test (1978) Cortex, 14, pp. 41-49
• Dexter, D.T., Wells, F.R., Lees, A.J., Agid, F., Agyd, Y., Jenner, G., Marsden, C.D., Increased nigral iron content and alterations in other metals ions occurring in brain in Parkinson's disease (1989) J Neurochem, 52, pp. 1830-1836
• Famulari, A.L., Marschoff, E.R., Llesuy, S.F., Kohan, S., Serra, J.A., Domínguez, R.O., Repetto, M., De Lustig, E.S., The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls (1996) J Neurol Sci, 141, pp. 69-78
• Faucheux, B.A., Martin, M.E., Beaumont, C., Hauw, J.J., Agid, Y., Hirsch, E.C., Protein involved in the regulation of intracellular iron (H and L-ferritin, iron regulatory protein) in the mesencephalon of patients with Parkinson's disease (1998) Soc Neurosci Abstr, 24 (2), p. 1466
• Folstein, M.F., Folstein, S.E., McHugh, P.R., Mini mental state: A practical method for grading the cognitive state of patient for the clinician (1975) J Psychiatry Res, 12, pp. 189-198
• Fraga, C.G., Leibovitz, B.E., Tappel, A.L.L., Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: Characterization and comparison with homogenates and microsomes (1988) Free Radic Biol Med, 4, pp. 155-161
• González Flecha, B., Llesuy, S., Boveris, A., Hydroperoxide initiated chemiluminescence: An assay of oxidative in biopsies of heart and liver (1991) Free Radic Biol Med, 10, pp. 93-100
• Good, P.F., Olanow, C.W., Perl, D.P., Neuromelanin-acontaining neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study (1992) Brain Res, 593, pp. 343-346
• Hamilton, M.A., Rating scale for depression (1960) J Neurol Neurosurg Psychiatry, 23, pp. 56-62
• Hattori, N., Tanaka, M., Ozawa, T., Mizuno, Y., Immunohisto-chemical studies on complexes I, II, III and IV of mitochondria in Parkinson's disease (1991) Ann Neurol, 30, pp. 563-571
• Hoehn, M.M., Yahr, M.D., Parkinsonism: Onset, progression and mortality (1967) Neurology, 17, pp. 427-442
• Hughes, A.J., Ben-Shlomo, S.E., Daniel, S.E., Lees, A.J., What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathological study (1992) Neurology, 2, pp. 1142-1146
• Hughes, C.P., Berg, L., Danziger, W.L., Coban, L.A., Martin, R.L., A new clinical scale for the staging of dementia (CDR) (1982) Br J Psychiatry, 140, pp. 566-572
• Jellinger, K.A., Cell death mechanisms in Parkinson's disease (2000) J Neural Transm, 107, pp. 1-29
• Jenner, P., Dexter, D.T., Sian, J., Schapira, A.H.V., Marsden, C.D., Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease (1992) Ann Neurol, 32, pp. S82-S87. , The Royal Kings and Queens Parkinson's Disease Research Group
• Lebart, L., Morineau, A., Fenelon, J.P., (1979) Traitement des donnes statistiques, , Dunod, Paris
• Lee, F., Developmental aspects of experimental pulmonary oxygen toxicity (1991) Free Radic Biol Med, 11, pp. 463-494
• Lissi, E., Pascual, C., Del Castillo, M., Luminol luminescence induced by 2-2′azo-bis (2 amidinopropane) thermolysis (1992) Free Radic Res Comms, 17, pp. 299-311
• Lowry, O.H., Rosenbrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1951) J Biol Chem, 193, pp. 265-275
• De Lustig, E.S., Serra, J.A., Kohan, S., Canziani, G.A., Famulari, A.L., Domínguez, R.O., Copper-zinc superoxide dismutase activity in red blood cells and serum in demented patients and in aging (1993) J Neurol Sci, 115, pp. 18-25
• Marcus, D.L., Thomas, C., Rodríguez, C., Simberkoff, K., Tsai, J.S., Strafaci, J.A., Freedman, M.L., Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease (1998) Exp Neurol, 150, pp. 40-44
• Marschoff, E.R., Domínguez, R.O., De Lustig, E.S., Famulari, A.L., Serra, J.A., Neurological deterioration, heterogeneity of Alzheimer disease and antioxidant profiles: A four trials meta-analysis (1997) J Neurol Sci, 150, pp. S22
• Marttila, R.J., Lorentz, H., Rinne, U.K., Oxygen toxicity protecting enzymes in the Parkinson's disease: Increase of superoxide dismutase-like activity in the substantia nigra and basal nucleus (1988) J Neurol Sci, 86, pp. 321-331
• McKhan, G., Drachman, D., Folstein, M., Katzman, R., Price, C., Stardlan, M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease (1984) Neurology, 34, pp. 939-944
• Michiels, C., Raes, M., Tousaint, O., Remacle, J., Importance of Se-glutathione peroxidase, catalase and Cu/Zn-SOD for cell survival against oxidative stress (1994) Free Radic Biol Med, 17 (3), pp. 235-248
• Misra, H.P., Fridovich, I., The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase (1972) J Biol Chem, 247, pp. 3170-3175
• Mizuno, Y., Sone, N., Saitoh, T., Dopaminergic neurotoxins. MPTP and MPP+, inhibit mitochondrial NADH-ubiquinone oxido-reductase activity (1986) Proc Jpn Acad, 62, pp. 261-263
• Morrison, D.F., (1976) Multivariate statistical methods, , McGraw-Hill, Tokyo
• Münch, G., Schinzel, R., Loske, C., Wong, A., Durany, N., Li, J.J., Vlassara, H., Riederer, P., Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts (1998) J Neural Transm, 105, pp. 439-461
• Nara, K., Konno, D., Uchida, J., Kiuchi, Y., Oguchi, K., Protective effect of nitric oxide against iron-induced neuronal damage (1999) J Neural Transm, 106, pp. 835-848
• O'Reilly, S.A., Roedica, J., Nagy, D., Hallewell, R.A., Alderson, K., Marklund, S.L., Kuby, J., Kushner, P.D., Motor-neuron astrocyte interactions and levels of Cu, Zn superoxide dismutase in sporadic amyotrophic lateral sclerosis (1995) Exp Neurol, 131, pp. 203-210
• Rahbar, A., Kempkes, M., Müller, Th., Reich, S., Welter, F.L., Meves, S., Przuntek, H., Kuhn, W., Glutathione S-transferase polymorphism in Parkinson's disease (2000) J Neural Transm, 107, pp. 331-334
• Reisberg, B., Ferris, Sh., De León, M.J., Crook, T., The global deterioration scale for assessment of primary degenerative dementia (1982) Am J Psychiatry, 139, pp. 1136-1139
• Rosen, G.W., Mohs, R., Davis, J.L., A new rating scale for Alzheimer's disease (1984) Am J Psychiatry, 141 (11), pp. 1356-1363
• Ruberg, M., France-Lanord, V., Brugg, B., Lambeng, N., Michel, P.P., Anglade, P., Hunot, S., Agid, Y., Neuronal death caused by apoptosis in Parkinson disease (1997) Neurol (Paris), 153 (8-9), pp. 499-508
• Serra, J.A., Famulari, A.L., Kohan, S., Marschoff, E.R., Domínguez, R.O., De Lustig, E.S., Copper-zinc superoxide dismutase activity in red blood cells in probable Alzheimer's patients and their first-degree relatives (1994) J Neurol Sci, 122, pp. 179-188
• Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D., Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia (1994) Ann Neurol, 36, pp. 348-355
• Sinet, P.M., Metabolism of oxygen derivatives in Down's syndrome (1982) Ann NY Acad Sci, 386, pp. 82-94
• Sofic, E., Paulus, W., Jellinger, K., Riederer, P., Youdim, M.B.H., Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains (1991) J Neurochem, 56, pp. 978-982
• Sokal, R.R., Rohlf, F.J., (1995) Biometry, 3th ed, , WH Freeman & Company, New York
• Warner, H.R., Superoxide dismutase, aging, and degenerative disease (1994) Free Radic Biol Med, 17 (3), pp. 249-258

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------